News & Events category:
NIHR Manchester Biomedical Research Centre
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Research finds interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination doubles antibody response.
Speech-friendly face mask could end frustration of muffled chat
A new face mask designed by Manchester researchers is promising to end the stress and anxiety talkers and listeners experience when they cover up.
MFT Cancer Professor features in Julia Bradbury breast cancer documentary
A leading MFT cancer professor MFT features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.
NHS develops world-first bedside genetic test to prevent babies going deaf
A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Prestigious national entrepreneurship scheme places awarded to three MFT staff members
Three budding MFT entrepreneurs have been awarded places on the prestigious NHS Clinical Entrepreneur Programme.
Trials carried out at MFT show drug eases symptoms of chronic cough
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
UK collaboration sees IMID BioResource pass major recruitment milestone
The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England.
First participants take part in study aboard Greater Manchester’s Research Van
The first participants have been involved in a study onboard Greater Manchester’s new state-of-the-art Research Van.